Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Sarcoma × Solutions × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Melanoma 2 Warts 1 Uterine Cervical Neoplasms 1 Tuberous Sclerosis 1 Squamous Cell Carcinoma of Head and Neck 1 Small Cell Lung Carcinoma 1 Seizures 1 Sarcoma 1 Prostatic Neoplasms 1 Ovarian Neoplasms 1 Metastatic Castration-resistant Prostate Cancer (mCRPC) 1 Lymphoma, T-Cell 1 Lennox Gastaut Syndrome 1 Hyperthermia 1 Hemorrhage 1 Hematologic Neoplasms 1 Haloperidol 1 Epilepsies, Myoclonic 1 Carcinoma, Transitional Cell 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma 1 Brain Neoplasms 1

Interventions

Doxorubicin 15 pembrolizumab 9 Surgical Procedures, Operative 8 Gemcitabine 8 Blood Specimen Collection 7 Nivolumab 6 Ifosfamide 6 Trabectedin 5 Surveys and Questionnaires 5 Drug Therapy 5 Cyclophosphamide 5 anlotinib 4 Temozolomide 4 Radiotherapy 4 Radiation Dose Hypofractionation 4 pazopanib 3 liposomal doxorubicin 3 fludarabine 3 atezolizumab 3 Specimen Handling 3 Radiation 3 Observation 3 Magnetic Resonance Spectroscopy 3 Ipilimumab 3 Docetaxel 3 Dacarbazine 3 Biopsy 3 trastuzumab deruxtecan 2 selinexor 2 repotrectinib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03886311 2025-02-24

TNT

Sarcoma Oncology Research Center, LLC

Phase 2 Recruiting

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡